Treatment of Visceral Leishmaniasis in Bihar

1 Anonymous. Report of informal meeting on the chemotherapy of visceral leishmaniasis. WHO/TDR/Chem Leish/VL/82.3. Geneva, 1982.

2 Wilcocks C Manson-Bahr PEC , eds. Manson's tropical diseases. London: Bailliere Tindall, 1972:117–47.

3 Thakur CP . Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar leishmaniasis). Trans R Soc Trop Med Hyg 1984;78:391–8.

4 Thakur CP Kumar M Singh SK Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Br Med J 1984;288:895–7.

5 Rees PH Keating MI Kager PA Hockmeyer WT . Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet 1980;ii:226–9.

6 Rees PH Kager PA Wellde BT Hockmeyer WT . The responses of Kenya kala-azar to treatment with sodium stibogluconate. Am J Trop Med Hyg 1984;33:357–61.

7 Kager PA Rees PH Wellde BT Hockmeyer WT Lyerly WH . Allopurinol in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1981;75:556–9.

8 Murphy KJ Bong ACS . Co-trimoxazole for systemic leishmaniasis. Lancet 1983;i:323–4.

9 Guradia J . Co-trimoxazole for kala-azar. Lancet 1981;i:501.

10 Peters W Lainson R Shaw JJ Robinson BL Leão A França . Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Lancet 1981;i: 1122–4.

11 Schattenkerk JKME Bhatt SM Rees PH . Antituberculous drugs and kala-azar. Lancet 1981;ii:304.